PURPOSE: To explore the relationships between nephrostomy tube (NT) size and outcome of percutaneous nephrolithotomy (PCNL). METHODS: The Clinical Research Office of the Endourological Society (CROES) prospectively collected data from consecutive patients treated with PCNL over a 1-year period at 96 participating centers worldwide. This report focuses on the 3,968 patients who received a NT of known size. Preoperative, surgical procedure and outcome data were analyzed according to NT size, dividing patients into two groups, namely small-bore (SB; nephrostomy size ≤ 18 Fr) and large-bore (LB; nephrostomy size > 18 Fr) NT. RESULTS: Patients who received a LB NT had a significantly lower rate of hemoglobin reduction (3.0 vs. 4.3 g/dL; P < 0.001), overall complications (15.8 vs. 21.4%; P < 0.001) and a trend toward a lower rate of fever (9.1 vs. 10.7%). Patients receiving a LB NT conversely had a statistically, though not clinically significant, longer postoperative hospital stay (4.4 vs. 4.2 days; P = 0.027). There were no differences in urinary leakage (0.9 vs. 1.3%, P = 0.215) or stone-free rates (79.5 vs. 78.1%, P = 0.281) between the two groups. CONCLUSIONS: LB NTs seem to reduce bleeding and overall complication rate. These findings would suggest that if a NT has to be placed, it should better be a LB one.
PURPOSE: To explore the relationships between nephrostomy tube (NT) size and outcome of percutaneous nephrolithotomy (PCNL). METHODS: The Clinical Research Office of the Endourological Society (CROES) prospectively collected data from consecutive patients treated with PCNL over a 1-year period at 96 participating centers worldwide. This report focuses on the 3,968 patients who received a NT of known size. Preoperative, surgical procedure and outcome data were analyzed according to NT size, dividing patients into two groups, namely small-bore (SB; nephrostomy size ≤ 18 Fr) and large-bore (LB; nephrostomy size > 18 Fr) NT. RESULTS:Patients who received a LB NT had a significantly lower rate of hemoglobin reduction (3.0 vs. 4.3 g/dL; P < 0.001), overall complications (15.8 vs. 21.4%; P < 0.001) and a trend toward a lower rate of fever (9.1 vs. 10.7%). Patients receiving a LB NT conversely had a statistically, though not clinically significant, longer postoperative hospital stay (4.4 vs. 4.2 days; P = 0.027). There were no differences in urinary leakage (0.9 vs. 1.3%, P = 0.215) or stone-free rates (79.5 vs. 78.1%, P = 0.281) between the two groups. CONCLUSIONS: LB NTs seem to reduce bleeding and overall complication rate. These findings would suggest that if a NT has to be placed, it should better be a LB one.
Authors: Luigi Cormio; Antonia Perrone; Giuseppe Di Fino; Nicola Ruocco; Mario De Siati; Jean de la Rosette; Giuseppe Carrieri Journal: J Urol Date: 2012-05-15 Impact factor: 7.450
Authors: Akito Yamaguchi; Andreas Skolarikos; Niels-Peter Noor Buchholz; Gonzalo Bueno Chomón; Michael Grasso; Pietro Saba; Stephen Nakada; Jean de la Rosette Journal: J Endourol Date: 2011-05-13 Impact factor: 2.942
Authors: Jean de la Rosette; Dean Assimos; Mahesh Desai; Jorge Gutierrez; James Lingeman; Roberto Scarpa; Ahmet Tefekli Journal: J Endourol Date: 2011-01 Impact factor: 2.942
Authors: Hemendra N Shah; Hiren S Sodha; Amit A Khandkar; Shabbir Kharodawala; Sunil S Hegde; Manish B Bansal Journal: J Endourol Date: 2008-07 Impact factor: 2.942
Authors: Paul K Pietrow; Brian K Auge; Costas D Lallas; Robert W Santa-Cruz; Glenn E Newman; David M Albala; Glenn M Preminger Journal: J Endourol Date: 2003-08 Impact factor: 2.942
Authors: A Häcker; A Bachmann; T Herrmann; R Homberg; J Klein; H Leyh; A Miernik; C Netsch; P Olbert; J Rassweiler; M Schoenthaler; K D Sievert; J Westphal; A J Gross Journal: Urologe A Date: 2016-10 Impact factor: 0.639